Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

Endpoints News

By Anna Brown and Ayisha Sharma

July 25, 2024

Cell and gene therapy company ViroCell Biologics has signed a five-year agreement with an unnamed cancer center in the US. ViroCell will manufacture lentivirus vectors for the cancer center to use in a clinical study testing a T cell receptor therapy. The center will also gain access to ViroCell’s other clinical and commercial services, according to a Tuesday release.